Research Topics
| Jason KoutcherSummaryAffiliation: Memorial Sloan-Kettering Cancer Center Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Multimodality registration without a dedicated multimodality scannerBradley J Beattie
Momorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Mol Imaging 6:108-20. 2007....
Detection of prostate cancer with MR spectroscopic imaging: an expanded paradigm incorporating polyaminesAmita Shukla-Dave
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10021 USA
Radiology 245:499-506. 2007....
Average arterial input function for quantitative dynamic contrast enhanced magnetic resonance imaging of neck nodal metastasesAmita Shukla Dave
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
BMC Med Phys 9:4. 2009..Further validation of the Avg-AIF approach with a larger population and in multiple regions is desirable...
MRI of mouse models for gliomas shows similarities to humans and can be used to identify mice for preclinical trialsJason A Koutcher
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Neoplasia 4:480-5. 2002..In contrast, low-grade murine oligodendrogliomas do not reveal contrast enhancement, similar to human tumors. MRI can be used to identify mice with brain neoplasms as inclusion criteria in preclinical trials...
An 19F magnetic resonance-based in vivo assay of solid tumor methotrexate resistance: proof of principleWilliam M Spees
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Clin Cancer Res 11:1454-61. 2005..Here we show the utility of an (19)F-labeled methotrexate (FMTX) with (19)F magnetic resonance to differentiate between sensitive and resistant tumors in vivo and thus predict therapeutic response...
Dual targeting of EGFR can overcome a major drug resistance mutation in mouse models of EGFR mutant lung cancerLucia Regales
Pao Laboratory, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA
J Clin Invest 119:3000-10. 2009..Moreover, this approach could serve as an important model for targeting other receptor tyrosine kinases activated in human cancers...
mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastomaXiaoyi Hu
Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Neoplasia 7:356-68. 2005....
Non-invasive molecular and functional imaging of cytosine deaminase and uracil phosphoribosyltransferase fused with red fluorescence proteinLigang Xing
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York 10065, USA
Acta Oncol 47:1211-20. 2008..Thus, we developed a preclinical tumor model to investigate the feasibility of using magnetic resonance spectroscopy and optical imaging to measure non-invasively CD and UPRT expression and function...
Development of new mouse lung tumor models expressing EGFR T790M mutants associated with clinical resistance to kinase inhibitorsLucia Regales
Pao Lab, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America
PLoS ONE 2:e810. 2007..The EGFR T790M mutation confers acquired resistance to kinase inhibitors in human EGFR mutant lung adenocarcinoma, is occasionally detected before treatment, and may confer genetic susceptibility to lung cancer...
Imaging of dihydrofolate reductase fusion gene expression in xenografts of human liver metastases of colorectal cancer in living ratsPhilipp Mayer-Kuckuk
Molecular Pharmacology and Therapeutics Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Eur J Nucl Med Mol Imaging 30:1281-91. 2003..It is concluded that the two examined nucleotide imaging methods are feasible techniques for monitoring of DHFR-HSV TK fusion protein expression in hepatic colorectal tumor tissue in living animals...
Feasibility of using limited-population-based average R10 for pharmacokinetic modeling of osteosarcoma dynamic contrast-enhanced magnetic resonance imaging dataWei Huang
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Magn Reson Imaging 27:852-8. 2009..61+/-0.19 and 0.55+/-0.14) obtained with the average R(10) approach. The results suggest that it is feasible, as well as practical, to use a limited-population-based average R(10) for pharmacokinetic modeling of osteosarcoma DCE-MRI data...
Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomyKristen L Zakian
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
Radiology 234:804-14. 2005..To determine whether hydrogen 1 magnetic resonance (MR) spectroscopic imaging can be used to predict aggressiveness of prostate cancer...
Preliminary assessment of magnetic resonance spectroscopic imaging in predicting treatment outcome in patients with prostate cancer at high risk for relapseDarko Pucar
Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Clin Prostate Cancer 3:174-81. 2004..Although MRSI did not provide added prognostic value to MRI in this small number of patients, MRSI might increase the confidence of the clinician in assessing risk on MRI by contributing supporting metabolic data...
High-resolution imaging of bone precursor cells within the intact bone marrow cavity of living micePhilipp Mayer-Kuckuk
In Vivo Cellular Molecular Imaging Center, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Mol Ther 12:33-41. 2005..In summary, we describe a versatile platform suitable for studying the biology of many bone marrow cell types in living bone...
Liver regeneration in humans is characterized by significant changes in cellular phosphorus metabolism: assessment using proton-decoupled 31P-magnetic resonance spectroscopic imagingKristen L Zakian
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Magn Reson Med 54:264-71. 2005..This study demonstrates that 31P MRSI can be used to assess metabolic changes in humans during liver regeneration, and may be useful for assessing derangement of the regenerative process or guiding adjuvant chemotherapies...
J-difference lactate editing at 3.0 Tesla in the presence of strong lipidsMari A Smith
Department of Medical Physics, Mail Box 84, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
J Magn Reson Imaging 28:1492-8. 2008..To implement in vivo detection of lactate in the presence of lipids by proton magnetic resonance spectroscopy at a 3 Tesla (T) field strength for potential applications in human tumors outside of the brain...
1H magnetic resonance spectroscopy of prostate cancer: biomarkers for tumor characterizationKristen L Zakian
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, NY, USA
Cancer Biomark 4:263-76. 2008..This article reviews the assessment of choline-containing compounds, citrate, and polyamines as markers for prostate tumor detection and aggressiveness...
The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysisAmita Shukla Dave
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
BJU Int 99:786-93. 2007..To design new models that combine clinical variables and biopsy data with magnetic resonance imaging (MRI) and MR spectroscopic imaging (MRSI) data, and assess their value in predicting the probability of insignificant prostate cancer...
Chronic prostatitis: MR imaging and 1H MR spectroscopic imaging findings--initial observationsAmita Shukla-Dave
Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Radiology 231:717-24. 2004..To determine whether chronic prostatitis affects three-dimensional proton magnetic resonance (MR) spectroscopic imaging in evaluation of disease in the peripheral zone...
Registration of planar bioluminescence to magnetic resonance and x-ray computed tomography images as a platform for the development of bioluminescence tomography reconstruction algorithmsBradley J Beattie
Memorial Sloan Kettering Cancer Center, Department of Neurology, 1275 York Avenue, New York, New York 10065, USA
J Biomed Opt 14:024045. 2009..36+/-0.23 mm. Additional experiments highlight some of the confounds that are often overlooked in the BLT reconstruction process, and for two of these confounds, simple corrections are proposed...
Murine S factors for liver, spleen, and kidneyKatherine S Kolbert
Imaging and Spectroscopic Physics Service, Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
J Nucl Med 44:784-91. 2003..Absorbed fractions for 5 monoenergetic electrons, ranging in energy from 0.5 to 2 MeV, are also provided...
Semi-automatic deformable registration of prostate MR images to pathological slicesYousef Mazaheri
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
J Magn Reson Imaging 32:1149-57. 2010..To present a semi-automatic deformable registration algorithm for co-registering T2-weighted (T2w) images of the prostate with whole-mount pathological sections of prostatectomy specimens...
Pharmacokinetics and Biodistribution of (86)Y-Trastuzumab for (90)Y dosimetry in an ovarian carcinoma model: correlative MicroPET and MRIStig Palm
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
J Nucl Med 44:1148-55. 2003..MicroPET and MRI-based preclinical biodistribution and localization data were obtained and used to assess the therapeutic potential of (90)Y-trastuzumab monoclonal antibody (mAb) (anti-HER2/neu) against ovarian carcinoma...
Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging--initial resultsKristen L Zakian
Departments of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Radiology 229:241-7. 2003..To determine whether cancers of the prostate transition zone (TZ) possess a unique metabolic pattern by which they may be identified at proton magnetic resonance (MR) spectroscopic imaging...
An exploratory study of endorectal magnetic resonance imaging and spectroscopy of the prostate as preoperative predictive biomarkers of biochemical relapse after radical prostatectomyKristen L Zakian
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
J Urol 184:2320-7. 2010..We determined whether pretreatment endorectal magnetic resonance imaging/magnetic resonance spectroscopic imaging predicts biochemical recurrence after radical prostatectomy...
A fluorine-labeled methotrexate as a probe for monitoring tumor antifolate pharmacokinetics: synthesis, in vitro cytotoxicity, and pilot in vivo 19F magnetic resonance spectraWilliam M Spees
Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Mol Cancer Ther 2:933-9. 2003....
Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findingsYousef Mazaheri
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Room C 278, New York, NY 10021, USA
Radiology 246:480-8. 2008....
Expression of the bifunctional suicide gene CDUPRT increases radiosensitization and bystander effect of 5-FC in prostate cancer cellsLigang Xing
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Radiother Oncol 92:345-52. 2009....
Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volumeYousef Mazaheri
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Room C 278, New York, NY 10065, USA
Radiology 252:449-57. 2009....
Proton MRS detects metabolic changes in hormone sensitive and resistant human prostate cancer models CWR22 and CWR22rH Carl Le
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Magn Reson Med 62:1112-9. 2009..01). Metabolic changes in total choline by proton MRSI can be used as an early biomarker of response for advanced-stage prostate cancer in targeted therapy such as 17-allylamino, 17-demethoxygeldanamycin...
Identification of prognostic markers in bone sarcomas using proton-decoupled phosphorus magnetic resonance spectroscopyKristen L Zakian
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Cancer Res 63:9042-7. 2003..The results are promising, although a prospective study is necessary for confirmation. (31)P MRSI appears to be a useful tool for the prediction of survival before therapy in bone sarcomas...
Fat-free MRI based on magnetization exchangeJin Hong Chen
Sarcoma Disease Management Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
Magn Reson Med 63:713-8. 2010..Unlike most fat suppression techniques, this method is not compromised by the static or radiofrequency field heterogeneity and is equally efficient for all fat resonances independent of their chemical shift frequency...
Metabolic response of the CWR22 prostate tumor xenograft after 20 Gy of radiation studied by 1H spectroscopic imagingJonathan P Dyke
Citigroup Biomedical Imaging Center, Department of Radiology, Weill Cornell Medical College, New York, New York 10021, USA
Clin Cancer Res 9:4529-36. 2003..CONCLUSIONS: Nuclear magnetic resonance spectroscopy provided a method with which to monitor metabolic changes of tumor response to XRT that preceded and predicted PSA and tumor volume changes...
Feasibility of using limited-population-based arterial input function for pharmacokinetic modeling of osteosarcoma dynamic contrast-enhanced MRI dataYa Wang
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Magn Reson Med 59:1183-9. 2008..Further validation with a larger population and multiple regions is desirable...
Image-fusion of MR spectroscopic images for treatment planning of gliomasJenghwa Chang
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA
Med Phys 33:32-40. 2006..In conclusion, an image-fusion protocol was developed that successfully incorporates MRSI information into the IMRT treatment plan for glioma...
Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancerBrett S Carver
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Cancer Cell 19:575-86. 2011....
Accuracy and reproducibility of tumor positioning during prolonged and multi-modality animal imaging studiesMutian Zhang
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Phys Med Biol 53:5867-82. 2008..The process of transporting the animal between instruments introduced additional errors of approximately 0.2 mm. In serial animal imaging studies, the positioning reproducibility within approximately 0.8 mm could be obtained...
Noninvasive multimodality imaging of the tumor microenvironment: registered dynamic magnetic resonance imaging and positron emission tomography studies of a preclinical tumor model of tumor hypoxiaHyungJoon Cho
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Neoplasia 11:247-59, 2p following 259. 2009....
Imaging transgene activity in vivoTerence P F Gade
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Cancer Res 68:2878-84. 2008..This study presents a translational imaging paradigm for precise, in vivo measurements of transgene activity with potential applications in both preclinical and clinical settings...
Targeted elimination of prostate cancer by genetically directed human T lymphocytesTerence P F Gade
Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Cancer Res 65:9080-8. 2005..These results thus provide a strong rationale for undertaking phase I clinical studies to assess PSMA-targeted T cells in patients with metastatic prostate cancer...
Pten dose dictates cancer progression in the prostateLloyd C Trotman
Molecular Biology Program, Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute, New York, New York, USA
PLoS Biol 1:E59. 2003..Our results provide conclusive genetic support for the notion that PTEN is haploinsufficient in tumor suppression and that its dose is a key determinant in cancer progression...
Dose-dependent effects of platelet-derived growth factor-B on glial tumorigenesisAlan H Shih
Department of Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Cancer Res 64:4783-9. 2004..Our data show that PDGFR signaling quantitatively regulates tumor grade and is required to sustain high-grade oligodendrogliomas...
Atrasentan (ABT-627) enhances perfusion and reduces hypoxia in a human tumor xenograft modelKwang Mo Yang
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Cancer Biol Ther 8:1940-6. 2009..Although Atrasentan had no independent effect on the growth of HT29 tumors, Atrasentan combined with 20 Gy radiation led to a modest but significant increase in tumor growth delay compared to radiation alone...
Preclinical evaluation of tumor microvascular response to a novel antiangiogenic/antitumor agent RO0281501 by dynamic contrast-enhanced MRI at 1.5 TManickam Muruganandham
Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Mol Cancer Ther 5:1950-7. 2006..Its effects on tumor vasculature can be monitored and assessed by DCE-MRI on a 1.5 T human MR scanner with clinically available gadopentetate dimeglumine contrast, which will facilitate clinical trials with this or similar agents...
Development of a new reporter gene system--dsRed/xanthine phosphoribosyltransferase-xanthine for molecular imaging of processes behind the intact blood-brain barrierMikhail Doubrovin
Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box 513, New York, NY 10021, USA
Mol Imaging 2:93-112. 2003..quot; Therefore, the novel dsRed/XPRT fusion gene can be used as a multimodality reporter system in the biological applications requiring two independent reporter genes, including the cells located behind the BBB...
Osteogenic and Ewing sarcomas: estimation of necrotic fraction during induction chemotherapy with dynamic contrast-enhanced MR imagingJonathan P Dyke
Department of Radiology, Weill Medical College of Cornell University, 1300 York Ave, Box 234, New York, NY 10021 4885, USA
Radiology 228:271-8. 2003..The ability to determine response to induction chemotherapy by means of noninvasive monitoring of necrotic fraction with perfusion MR imaging methods may provide useful prognostic information and help surgical planning...
Noninvasive assessment of tumor microenvironment using dynamic contrast-enhanced magnetic resonance imaging and 18F-fluoromisonidazole positron emission tomography imaging in neck nodal metastasesJacobus F A Jansen
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Int J Radiat Oncol Biol Phys 77:1403-10. 2010....
Imaging intratumoral convection: pressure-dependent enhancement in chemotherapeutic delivery to solid tumorsTerence P F Gade
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Clin Cancer Res 15:247-55. 2009..We investigated the hypothesis that improved intratumoral convection can alter tumor metabolism and enhance the delivery of a LMW chemotherapeutic agent to solid tumors...
In vivo 5-fluorouracil and fluoronucleotide T1 relaxation time measurements using the variable nutation angle methodTerence P F Gade
Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Magn Reson Med 52:169-73. 2004..The determined T1's for 5FU and FNuc (2.3 +/- 0.1 s and 1.3 +/- 0.1 s, respectively) represent the first reported in vivo measurements for these metabolites in tumor...
In vivo tumor lactate relaxation measurements by selective multiple-quantum-coherence (Sel-MQC) transferManickam Muruganandham
Department of Medical Physics and Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
Magn Reson Med 52:902-6. 2004..The present approach will allow investigators to correct for the relaxation-induced Lac signal loss in Sel-MQC experiments for the quantitative mapping of in vivo tumor Lac distribution...
Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy-initial experienceDarko Pucar
Department of Radiology, Medical Physics, Epidemiology and Biostatistics, Urology, Pathology, and Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
Radiology 236:545-53. 2005..CONCLUSION: In summary, MR imaging and MR spectroscopy may be more sensitive than sextant biopsy and digital rectal examination for sextant localization of cancer recurrence after external-beam radiation therapy...
Metabolic signatures associated with a NAD synthesis inhibitor-induced tumor apoptosis identified by 1H-decoupled-31P magnetic resonance spectroscopyManickam Muruganandham
Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Clin Cancer Res 11:3503-13. 2005....
In vivo 19F magnetic resonance spectroscopy and chemical shift imaging of tri-fluoro-nitroimidazole as a potential hypoxia reporter in solid tumorsDaniel Procissi
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Clin Cancer Res 13:3738-47. 2007....
Detection and quantitative analysis of early stage orthotopic murine bladder tumor using in vivo magnetic resonance imagingEiji Kikuchi
Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
J Urol 170:1375-8. 2003..The improved resolution that we report compared with previous murine bladder studies highlights its potential for monitoring the therapeutic efficacy of antitumor agents for early superficial bladder tumors...
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesisZhenbang Chen
Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute, 1275 York Avenue, New York, New York 10021, USA
Nature 436:725-30. 2005..Our results demonstrate the relevance of cellular senescence in restricting tumorigenesis in vivo and support a model for cooperative tumour suppression in which p53 is an essential failsafe protein of Pten-deficient tumours...
Magnetic resonance spectroscopy and clinical cancer prognosisKristen L Zakian
Acad Radiol 11:365-7. 2004
Prediction of treatment response of head and neck cancers with P-31 MR spectroscopy from pretreatment relative phosphomonoester levelsAmita Shukla-Dave
Dept of Radiology, University of Pennsylvania Medical Center, Philadelphia, USA
Acad Radiol 9:688-94. 2002..0 +/- 0.0 vs 1.22 +/- 0.17 [P = .004]). CONCLUSION: Results of this preliminary study suggest that H-1-decoupled P-31 magnetic resonance spectroscopy may prove to be a useful predictor of therapeutic response in head and neck cancers...
The absence of p53 promotes metastasis in a novel somatic mouse model for hepatocellular carcinomaBrian C Lewis
University of Massachusetts Medical School, 364 Plantation St, LRB 521, Worcester, MA 01605, USA
Mol Cell Biol 25:1228-37. 2005..Tumors induced in p53 null, TVA transgenic mice by PyMT mutants with changes in specific tyrosine residues fail to form metastases, indicating that metastasis is dependent on both the oncogene and the absence of p53...
Evidence for shutter-speed variation in CR bolus-tracking studies of human pathologyThomas E Yankeelov
Chemistry Department, Brookhaven National Laboratory, Upton, NY 11973, USA
NMR Biomed 18:173-85. 2005..Normal muscle regions in the leg allow validation of the shutter-speed model K(trans), v(e), and tau(i) magnitudes, by comparison with results of previous careful rat leg studies not possible for human subjects...
Research Grants
- 500 MHz Wide Bore NMR SystemJason Koutcher; Fiscal Year: 2002..Thus this proposal, if funded , will support a very broad base of scientist and medical researchers in this area. ..
- 9.4T/20 cm MRI for Cancer ResearchJason Koutcher; Fiscal Year: 2007..The approaches to addressing these problems are quite varied but have in common the feasibility to readily translate any of these findings from the preclinical to the clinical realm, based on existing technology. ..
- Cytocidal Therapy In Vivo for Drug-Resistant TumorsJason Koutcher; Fiscal Year: 2007..If validated clinically, the proposed therapy will open the way for cure of metastatic breast cancer, and the therapeutic strategy likely will apply to other drug-resistant types of cancer. ..
- Memorial Sloan Kettering Small Animal Imaging ResearchJason Koutcher; Fiscal Year: 2007..abstract_text> ..
- Dynamic Magnetic Resonance Imaging of Bone TumorsJason Koutcher; Fiscal Year: 2007..If successful, it will provide a tool to predict failure/response to chemotherapy, resulting in patient specific treatment which will likely enhance outcome. ..
- Optimizing Chemotherapy Dose Using 31P NMR SpectroscopyJason Koutcher; Fiscal Year: 2006..The doses determined in these studies, will allow further Phase II studies of this strategy. If measurements of 6PG in peripheral blood lymphocytes correlate with tumor 6PG, future studies would not require further NMR studies. ..
- Cytocidal Therapy In Vivo for Drug-Resistant TumorsJason Koutcher; Fiscal Year: 2005..If validated clinically, the proposed therapy will open the way for cure of metastatic breast cancer, and the therapeutic strategy likely will apply to other drug-resistant types of cancer. ..
